Sun Pharma Advanced Research Company Ltd share price logo

Sun Pharma Advanced Research Company Ltd

NSE: SPARC

BSE: 532872

Small Cap

Pharma Sector

₹186.42

-1.58

(-0.84%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Sun Pharma Advanced Research shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-51%

Searches for Sun Pharma Advanced Research on INDmoney have decreased by 51% over the last 30 days.

Investment activity on INDmoney

-54.42%

Investment activity in Sun Pharma Advanced Research among INDmoney users has decreased by 54.42% over the last 30 days.

Average holding period of indmoney investors

14 days

INDmoney investors hold Sun Pharma Advanced Research shares for an average of 14 days.

Sun Pharma Advanced Research Stock Performance

as on September 16, 2026 at 6:42 pm IST

  • Day's Low

    Day's High

    ₹182.00
    ₹190.81
    downward going graph

    2.37%

    Downside

    2.35%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹108.00
    ₹289.00
    downward going graph

    42.07%

    Downside

    55.03%

    Upside

    downward going graph

Sun Pharma Advanced Research share price movements today

Previous Close
₹188.00
Open
₹186.50
Volume
5.12L
Upper Circuit
₹206.80
Lower Circuit
₹169.20
Day's Low - High
₹182.00 - ₹190.81
52 Week Low - High
₹108.00 - ₹289.00

Sun Pharma Advanced Research Historical Returns

1 Month Return
-4.74 %
3 Month Return
-21.14 %
1 Year Return
+ 30.72 %
3 Year Return
-19.91 %
5 Year Return
-37.36 %

Sun Pharma Advanced Research Fundamentals

as on September 16, 2026 at 1:12 pm IST

Market Cap

₹6,101.01 Cr

Return on Equity (ROE)

164.77

PE Ratio (TTM)

4.02

Return on capital employed (ROCE)

111.09

Industry PE ratio

51.81

Beta (LTM)

1.75

P/B Ratio

2.79

Dividend Yield

0

PEG Ratio

0.07

Quarterly Earnings Growth YOY

-59.94

EPS (TTM)

47.86

Book Value

41.25

Sun Pharma Advanced Research Stock Valuation

as on September 16, 2026 at 1:12 pm IST

Sun Pharma Advanced Research in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (4.02x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (5.69x)

July 9, 2026

LowHigh

Today’s Price to Earnings Ratio: 4.02x

Sun Pharma Advanced Research Technical Analysis

Track how Sun Pharma Advanced Research technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish7
Bullish4
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bearish
CCI (20)
-18.6
Neutral
RSI (14)
43.87
Neutral
Momentum (10)
-0.21
Bearish
ADI (14)
19.83
Neutral
Ultimate Oscillator (7,14,28)
46.62
Neutral

Moving Averages

Name

Value

Action

SMA (20)
186.32
Bearish
EMA (20)
186.23
Bearish
VWMA (20)
186.24
Bearish
SMA (50)
186.03
Bullish
EMA (50)
186.16
Bearish
SMA (200)
185.87
Bullish
EMA (200)
186.23
Bearish
KAMA (200)
186
Bullish
DEMA (200)
185.51
Bullish

Sun Pharma Advanced Research Company Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sun Pharma Advanced Research with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA6,101.01-7.47%0.661,5531,879
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,206.82-4.25%0.621502,268
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY16,120.3612.3%0.733978,279
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,764.7444.58%0.682811,703
Poly Medicure Ltd image
Poly Medicure Ltd
BUY17,278.0815.65%0.573201,875
See all

Sun Pharma Advanced Research Company Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
21.18
13.86
16.56
16.81
12.86
14.91
27.19
9.64
7.86
8.45
13.2
39.92
Other Income
8.49
6.39
4.4
1.56
0.04
0.19
-
9.14
0.01
-
1.8
23.66
Total Income
29.67
20.25
20.96
18.37
12.9
15.1
27.19
18.78
7.87
8.45
1,855.02
63.58
Expenses
112.65
116.48
122.39
110.17
115.77
88.6
80.37
61.72
73.58
77.45
80.02
73.92
Operating Profit
-91.47
-102.62
-105.83
-93.36
-102.91
-73.69
-53.18
-52.08
-65.72
-69
-66.82
-34
Operating Profit Margin %
-431.87%
-740.4%
-639.07%
-555.38%
-800.23%
-494.23%
-195.59%
-540.25%
-836.13%
-816.57%
-506.21%
-85.17%
Profit Before Interest, Tax and Depreciation
-82.98
-96.23
-101.43
-91.8
-102.87
-73.5
-53.18
-42.94
-65.71
-69
1,775
-10.34
Interest
0.26
0.26
0.91
0.56
1.14
2.8
4.54
6.19
7.52
8.78
11.64
8.13
Depreciation
3.18
3.16
3.07
3.14
3.16
3.14
2.95
2.68
2.56
2.57
2.4
2.2
Profit Before Tax
-86.42
-99.65
-105.41
-95.5
-107.17
-79.44
-60.67
-51.81
-75.79
-80.35
1,760.96
-20.67
Tax Paid
-
-
0.38
0.4
0.16
0.07
-0.9
0.06
0.06
0.07
-0.38
0.11
Profit After Tax
-86.42
-99.65
-105.79
-95.9
-107.33
-79.51
-59.77
-51.87
-75.85
-80.42
1,761.34
-20.78
Total Net profit including share of profit / Loss from associate company
-86.42
-99.65
-105.79
-95.9
-107.33
-79.51
-59.77
-51.87
-75.85
-80.42
1,761.34
-20.78
EPS
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
-2.48
54.27
-0.64
Actual EPS
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
-2.48
54.27
-0.64
Adjusted EPS
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
-2.48
54.27
-0.64
Diluted EPS
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
-2.48
54.27
-0.64

Sun Pharma Advanced Research Company Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
238.78
75.55
71.77
39.15
Other Income
10.88
29.47
1.79
10.95
Total Income
249.66
105.02
73.56
1,890.12
Expenses
452.84
477.65
394.91
292.77
Operating Profit
-214.06
-402.1
-323.14
-253.62
Operating Profit Margin %
-89.65%
-532.23%
-450.24%
-647.82%
Profit Before Interest, Tax and Depreciation
-203.18
-372.63
-321.35
1,597.35
Interest
7.63
1.69
9.04
34.13
Depreciation
11.77
12.51
12.39
10.21
Profit Before Tax
-222.58
-386.83
-342.78
1,553.01
Tax Paid
-
0.38
-0.27
-0.19
Profit After Tax
-222.58
-387.21
-342.51
1,553.2
Total Net profit including share of profit / Loss from associate company
-222.58
-387.21
-342.51
1,553.2
EPS
-7.82
-11.93
-10.55
47.86
Actual EPS
-7.82
-11.93
-10.55
47.86
Adjusted EPS
-7.82
-11.93
-10.55
47.86
Diluted EPS
-7.82
-11.93
-10.55
47.86

Sun Pharma Advanced Research Company Ltd Cash Flow

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
-69.12
-429.19
-360.29
-238.78
Cash Flow from Investing Activities
-548.28
391.53
157.67
-23.42
Cash Flow from Financing Activities
616.75
42.41
199.25
261.39
Net Cash Flow
-0.64
4.75
-3.37
-0.81

Sun Pharma Advanced Research Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
May 2026
Jun 2026
Promoters
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
DII
0.81%
0.82%
0.18%
0.23%
0.64%
1.13%
0.97%
1.05%
0.78%
0.88%
0.1%
0.09%
FII
3.3%
3.23%
2.64%
2.15%
2.23%
1.45%
1.47%
1.76%
2.04%
2.04%
2.47%
3.9%
Public
30.21%
30.28%
31.51%
31.95%
31.46%
31.75%
31.88%
31.52%
31.5%
31.41%
31.76%
30.33%
Total Outstanding Shares
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
Total Shareholders
1,03,990
1,02,743
1,25,184
1,28,205
1,31,034
1,42,864
1,40,724
1,36,997
1,44,810
1,40,625
1,37,538
1,41,957

Mutual Funds Buying / Exiting Sun Pharma Advanced Research

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Sun Pharma Advanced Research

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.03 Cr

₹0.00 Cr (+9.32%)

0.12%

Groww Nifty Total Market Index Fund Direct Growth

Groww Nifty Total Market Index Fund Direct Growth

₹0.03 Cr

₹0.00 Cr (+0.32%)

0.01%

Mutual Funds Exiting Sun Pharma Advanced Research

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Sun Pharma Advanced Research Corporate Actions

View detailed summary of the earnings and dividend history of Sun Pharma Advanced Research.

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit jumped 59.94% since last year same period to ₹-20.78Cr in the Q1 2026-2027. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -101.18% fall in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Sun Pharma Advanced Research Stock

Check stock indices that include Sun Pharma Advanced Research.

BSE Healthcare

₹50,380.86

-97.95 (▲0.19%)

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.47% to 3.90% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 177.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 20.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 0.09% to 0.08% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SPARC stock has moved down by -6.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 31.76% to 30.33% in Jun 2026 quarter

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Revenue: ₹39.92Cr as on June 2026 (Q1 FY27)
Net Profit: ₹-20.78Cr as on June 2026 (Q1 FY27)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSun Pharma Advanced Research Company Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEODilip S Shanghvi
E-voting on sharesClick here to vote

FAQs

What is Sun Pharma Advanced Research share price today?

Sun Pharma Advanced Research share price today stands at ₹186.42 as on . Sun Pharma Advanced Research share today touched a day high of ₹190.81 and a low of ₹182.

What is the 52 week high and 52 week low range for Sun Pharma Advanced Research share?

Sun Pharma Advanced Research touched a 52 week high of ₹289 and a 52 week low of ₹108. Sun Pharma Advanced Research share price today i.e. is trending at ₹186.42, which is -35.49% down from its 52 week high and 72.61% up from its 52 week low.

What is Sun Pharma Advanced Research's market capitalisation today?

Sun Pharma Advanced Research market capitalisation is ₹6,101.01 Cr as on .

How to buy Sun Pharma Advanced Research shares?

To buy Sun Pharma Advanced Research shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SPARC or Sun Pharma Advanced Research Company Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sun Pharma Advanced Research shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sun Pharma Advanced Research trading volume today?

Sun Pharma Advanced Research trading volume is 5.12L as on . This means that 5.12L shares of Sun Pharma Advanced Research were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Sun Pharma Advanced Research shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Sun Pharma Advanced Research have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 14 days. This reflects platform activity only and is not investment advice.